October 7, 2004Vioxx Withdrawal Leads Consumers to Seek Out Pfizer's Celebrex and Other Anti-Inflammatory Drugs September 22, 2004PharmacyChecker.com Evaluates First Israeli Online Pharmacy to Market Directly to the Americans July 21, 2004PharmacyChecker.com Names Four Canadian Pharmacies Sourcing Drugs...
47 downloadable .pdfs on the economics of pharmacy benefits managers. ( PBMs) Formulary rebates, PBM business model, auction design, collusion, FTC, Abrams
Humana recruited their first resident and began the process to become an accredited residency program in 1997. Since then, Humana has hosted residents from thirty-three colleges of pharmacy located in twenty-two states and Washington, D.C. Including the 2023-2024 residency program graduates, 52/54...
47 downloadable .pdfs on the economics of pharmacy benefits managers. ( PBMs) Formulary rebates, PBM business model, auction design, collusion, FTC, Abrams
If you will become eligible for Medicare coverage for the first time in 2025, now is a good time to start learning about the different types of Medicare (i.e., Medicare Parts A, B, C, and D) and what they mean for you. The open enrollment period for Medicare 2025 begins October 15...
Expiration analysis of the International Space Station formulary for exploration mission planning Article Open access 23 July 2024 The effect of long-term spaceflight on drug potency and the risk of medication failure Article Open access 05 May 2023 Key points for the development of antioxidant...
2023 forecast: Amid dwindling COVID relief funds, rural hospitals face a ‘fiscal cliff’ (fiercehealthcare.com) In the first year of the pandemic, 19 rural hospitals closed their doors. Yet in the years since, only six have. What these historic lows might suggest is deceptive, experts ...
By entering a PBM, you’ll be exposed to formulary design and management, review processes for expensive medications used for complex conditions, and other drug therapy and utilization management programs. You’ll put your academic skills to use while improving drug coverage and quality of care...
Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist and pharmaceutical formulary manager at Mayo Clinic, reacts to the biggest FDA approvals of 2023 and how she sees the adalimumab, natalizumab, and tocilizumab spaces playing out. Dr Prerakkumar Parikh Reacts to FDA Approvals for First Neu...
Some drugs are well known to cause first-dose phenomena, and ADEs with other drugs commonly occur early in treatment. The solution for these problems would be to define and produce the lowest effective doses of medications, thereby facilitating their use in a wide range of clinical situations:...